T管缚附硅胶管内置支架在无法切除的肝门部胆管癌术中的应用

Application of T-tube Adhering Silicone Tube Stent in Unresectable Hepatic Portal Cholangiocarcinoma

目的探讨T管缚附硅胶管内置支架置入在不能切除的肝门部胆管癌手术中的可行性和临床应用价值。方法我院对8例术中发现无法根治切除的晚期肝门部胆管癌,经胆总管切开置入T管缚附硅胶管内置支架,完成胆汁内引流。结果 8例放置支架术后2周内黄疸消退,经T管造影显示胆道梗阻解除。8例随访6～36个月,平均12.5个月,7例死亡(生存期6～20个月,平均10个月),1例已经存活36个月。结论对术中发现无法根治切除的肝门部胆管癌,采用T管缚附硅胶管内置支架置入术进行治疗,能有效解除梗阻性黄疸,且操作简单,取材方便,费用低廉,是一种较好的姑息治疗方法。

Objective To explore the feasibility and clinical value of T-tube adhering silicone tube stent in unresectable hepaticportal cholangiocarcinoma.Methods T-tube adhering silicone tube stent was placed into the obstructive bile duct of 8 patients with unresectable hepatic portal cholangiocarcinoma for internal biliary drainage.Results 8 Patients＇jaundice disappeared within 2 weeks after the stent placement.Cholangiography via the drainage tube showed patent bile ducts.A 6 - 36 months＇ follow-up survey in 8 patients（12.5 months in average） showed a mean survival time of 6 - 20 months（10 months in average） in 7 fatal patients,while one patient had survived for 36 months.Conclusion Placement of T-tube adhering silicone tube stent for patients with unresectable hepatic portal cholangiocarcinoma is an ideal palliative therapy,which is simple,low cost and effective to reduce jaundice.